Collins Cooper C.
SEC insider (Form 3/4/5 filer). CIK 0001485508. Director at TherapeuticsMD, Inc. (TXMD). 2 reported Form 4/5 transactions since Sep 2024; latest on Nov 3, 2025. Located in BOCA RATON, FL.
Companies Collins Cooper C. has filed insider reports for
- TherapeuticsMD, Inc. (TXMD): Director
Collins Cooper C.
CIK: 0001485508
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (50.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TXMD
TherapeuticsMD, Inc.
Director